These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 38578532)

  • 1. STING pathway as a cancer immunotherapy: Progress and challenges in activating anti-tumor immunity.
    Tabar MMM; Fathi M; Kazemi F; Bazregari G; Ghasemian A
    Mol Biol Rep; 2024 Apr; 51(1):487. PubMed ID: 38578532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cyclic guanosine monophosphate synthase-stimulator of interferon genes pathway as a potential target for tumor immunotherapy.
    Chen R; Liu M; Jiang Q; Meng X; Wei J
    Front Immunol; 2023; 14():1121603. PubMed ID: 37153627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering and Delivery of cGAS-STING Immunomodulators for the Immunotherapy of Cancer and Autoimmune Diseases.
    Zhou S; Cheng F; Zhang Y; Su T; Zhu G
    Acc Chem Res; 2023 Nov; 56(21):2933-2943. PubMed ID: 37802125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting STING for cancer immunotherapy: From mechanisms to translation.
    Huang R; Ning Q; Zhao J; Zhao X; Zeng L; Yi Y; Tang S
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109304. PubMed ID: 36252492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between the SFTSV envelope glycoprotein Gn and STING inhibits the formation of the STING-TBK1 complex and suppresses the NF-κB signaling pathway.
    Jia Y; Li F; Liu Z; Liu S; Huang M; Gao X; Su X; Wang Z; Wang T
    J Virol; 2024 Mar; 98(3):e0181523. PubMed ID: 38421179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle-Mediated STING Activation for Cancer Immunotherapy.
    Li Y; Li X; Yi J; Cao Y; Qin Z; Zhong Z; Yang W
    Adv Healthc Mater; 2023 Jul; 12(19):e2300260. PubMed ID: 36905358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. African Swine Fever Virus Armenia/07 Virulent Strain Controls Interferon Beta Production through the cGAS-STING Pathway.
    García-Belmonte R; Pérez-Núñez D; Pittau M; Richt JA; Revilla Y
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30918080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies.
    Zhang J; Yu S; Peng Q; Wang P; Fang L
    Cancer Biol Med; 2024 Jan; 21(1):45-64. PubMed ID: 38172538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies involving STING pathway activation for cancer immunotherapy: Mechanism and agonists.
    Pan X; Zhang W; Guo H; Wang L; Wu H; Ding L; Yang B
    Biochem Pharmacol; 2023 Jul; 213():115596. PubMed ID: 37201875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.
    Zheng J; Mo J; Zhu T; Zhuo W; Yi Y; Hu S; Yin J; Zhang W; Zhou H; Liu Z
    Mol Cancer; 2020 Aug; 19(1):133. PubMed ID: 32854711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cGAS-STING Pathway in Bacterial Infection and Bacterial Immunity.
    Liu N; Pang X; Zhang H; Ji P
    Front Immunol; 2021; 12():814709. PubMed ID: 35095914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cGAS-STING signaling.
    Sun Z; Hornung V
    Curr Biol; 2022 Jul; 32(13):R730-R734. PubMed ID: 35820380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of innate immunity by the cGAS-STING pathway.
    Mosallanejad K; Kagan JC
    Immunol Cell Biol; 2022 Jul; 100(6):409-423. PubMed ID: 35485309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of cGAS-STING suppresses coxsackievirus replication via interferon-dependent signaling.
    Mohamud Y; Fu C; Fan YM; Zhang YL; Lin JFC; Hwang SW; Wang ZC; Luo H
    Antiviral Res; 2024 Feb; 222():105811. PubMed ID: 38242503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus.
    Cheng WY; He XB; Jia HJ; Chen GH; Jin QW; Long ZL; Jing ZZ
    Front Immunol; 2018; 9():1297. PubMed ID: 29963044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cGAS/STING/TBK1/IRF3 innate immunity pathway maintains chromosomal stability through regulation of p21 levels.
    Basit A; Cho MG; Kim EY; Kwon D; Kang SJ; Lee JH
    Exp Mol Med; 2020 Apr; 52(4):643-657. PubMed ID: 32284536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer.
    Storozynsky Q; Hitt MM
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activating Innate Immunity by a STING Signal Amplifier for Local and Systemic Immunotherapy.
    Song W; Song SJ; Kuang J; Yang H; Yu T; Yang F; Wan T; Xu Y; Wei ST; Li MX; Xiong Y; Zhou Y; Qiu WX
    ACS Nano; 2022 Oct; 16(10):15977-15993. PubMed ID: 36190834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STING activation in cancer immunotherapy.
    Su T; Zhang Y; Valerie K; Wang XY; Lin S; Zhu G
    Theranostics; 2019; 9(25):7759-7771. PubMed ID: 31695799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors.
    Li G; Zhao X; Zheng Z; Zhang H; Wu Y; Shen Y; Chen Q
    Cell Mol Life Sci; 2024 Mar; 81(1):149. PubMed ID: 38512518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.